Co-chaired by Dr Juan Gonzalez, Jose Mallolas, Juan Berenguer and Jose A Pineda.
Interventional Studies to optimize treatment of hepatitis C, including pharmacokinetics, pharmacoeconomics and resistance, focusing in pre-treated patients and Genotype IV.
WP4 contains research projects dealing with the management of HCV in HIV co-infected patients. The groups participating in these projects are widely recognized as international leaders in this particular field. All the eight studies are expected to have a paramount impact in salvage therapy, in the therapy of the difficult to treat genotype IV, in the consequences and evolution of the liver disease after the HCV eradication on the consequences and evolution after exposure to DAA and on better defining the indications of liver transplantation in HIV patients.